More articles from ENDOCRINE AND DIABETES

You have access
The Lyn Kinase Activator MLR-1023 Is a Novel Insulin Receptor Potentiator that Elicits a Rapid-Onset and Durable Improvement in Glucose Homeostasis in Animal Models of Type 2 Diabetes
Alexander R. Ochman, Christopher A. Lipinski, Jeffrey A. Handler, Andrew G. Reaume and Michael S. Saporito

Journal of Pharmacology and Experimental Therapeutics July 2012, 342 (1) 23-32; DOI: https://doi.org/10.1124/jpet.112.192187
You have access
Characterization of CCX140-B, an orally bioavailable antagonist of the CCR2 chemokine receptor, for the treatment of type 2 diabetes and associated complications
Timothy J Sullivan, Daniel J Dairaghi, Antoni Krasinski, Zhenhua Miao, Yu Wang, Bin N Zhao, Trageen Baumgart, Rob Berahovich, Linda S Ertl, Andrew Pennell, Lisa Seitz, Shichang Miao, Solomon Ungashe, Zheng Wei, Dan Johnson, Landin Boring, Chia-Lin Tsou, Israel F Charo, Pirow Bekker, Thomas J Schall and Juan C Jaen

Journal of Pharmacology and Experimental Therapeutics January 2012, jpet.111.190918; DOI: https://doi.org/10.1124/jpet.111.190918
You have access
Tofogliflozin, a Potent and Highly Specific Sodium/Glucose Cotransporter 2 Inhibitor, Improves Glycemic Control in Diabetic Rats and Mice
Masayuki Suzuki, Kiyofumi Honda, Masanori Fukazawa, Kazuharu Ozawa, Hitoshi Hagita, Takahiro Kawai, Minako Takeda, Tatsuo Yata, Mio Kawai, Taku Fukuzawa, Takamitsu Kobayashi, Tsutomu Sato, Yoshiki Kawabe and Sachiya Ikeda

Journal of Pharmacology and Experimental Therapeutics June 2012, 341 (3) 692-701; DOI: https://doi.org/10.1124/jpet.112.191593
You have access
Modeling Disease Progression and Rosiglitazone Intervention in Type 2 Diabetic Goto-Kakizaki Rats
Wei Gao and William J. Jusko

Journal of Pharmacology and Experimental Therapeutics June 2012, 341 (3) 617-625; DOI: https://doi.org/10.1124/jpet.112.192419
You have access
The Effects of TAK-875, a Selective G Protein-Coupled Receptor 40/Free Fatty Acid 1 Agonist, on Insulin and Glucagon Secretion in Isolated Rat and Human Islets
Hiroaki Yashiro, Yoshiyuki Tsujihata, Koji Takeuchi, Masatoshi Hazama, Paul R. V. Johnson and Patrik Rorsman

Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 483-489; DOI: https://doi.org/10.1124/jpet.111.187708
You have access
Dipeptidyl Peptidase IV Inhibitor Attenuates Kidney Injury in Streptozotocin-Induced Diabetic Rats
Wei Jing Liu, Shu Hua Xie, Yu Ning Liu, Won Kim, Heung Yong Jin, Sung Kwang Park, Yi Ming Shao and Tae Sun Park

Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 248-255; DOI: https://doi.org/10.1124/jpet.111.186866
You have access
Beneficial Effects of PKF275-055, a Novel, Selective, Orally Bioavailable, Long-Acting Dipeptidyl Peptidase IV Inhibitor in Streptozotocin-Induced Diabetic Peripheral Neuropathy
R. Bianchi, I. Cervellini, C. Porretta-Serapiglia, N. Oggioni, B. Burkey, P. Ghezzi, G. Cavaletti and G. Lauria

Journal of Pharmacology and Experimental Therapeutics January 2012, 340 (1) 64-72; DOI: https://doi.org/10.1124/jpet.111.181529
You have access
Modeling Diabetes Disease Progression and Salsalate Intervention in Goto-Kakizaki Rats
Yanguang Cao, Debra C. DuBois, Hao Sun, Richard R. Almon and William J. Jusko

Journal of Pharmacology and Experimental Therapeutics December 2011, 339 (3) 896-904; DOI: https://doi.org/10.1124/jpet.111.185686
You have access
TAK-875, an Orally Available G Protein-Coupled Receptor 40/Free Fatty Acid Receptor 1 Agonist, Enhances Glucose-Dependent Insulin Secretion and Improves Both Postprandial and Fasting Hyperglycemia in Type 2 Diabetic Rats
Yoshiyuki Tsujihata, Ryo Ito, Masami Suzuki, Ayako Harada, Nobuyuki Negoro, Tsuneo Yasuma, Yu Momose and Koji Takeuchi

Journal of Pharmacology and Experimental Therapeutics October 2011, 339 (1) 228-237; DOI: https://doi.org/10.1124/jpet.111.183772
You have access
Decreased Cytochrome c Oxidase IV Expression Reduces Steroidogenesis
Kevin J. Pawlak, Manoj Prasad, Kevin A. McKenzie, John P. Wiebe, C. Gary Gairola, Randy M. Whittal and Himangshu S. Bose

Journal of Pharmacology and Experimental Therapeutics August 2011, 338 (2) 598-604; DOI: https://doi.org/10.1124/jpet.111.182634

Main menu

User menu

Search

More articles from ENDOCRINE AND DIABETES

Pages

Navigate

More Information

ASPET's Other Journals